BioMarin Pharmaceuticals
BMRN
BMRN
525 hedge funds and large institutions have $22.3B invested in BioMarin Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 204 increasing their positions, 166 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
525
Holders Change
+27
Holders Change %
+5.42%
% of All Funds
10.79%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
88
Increased
204
Reduced
166
Closed
59
Calls
$222M
Puts
$182M
Net Calls
+$40.1M
Net Calls Change
+$1.78M
Top Buyers
| 1 |
BlackRock
New York
|
+$169M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
+$157M |
| 3 |
FAM
Fred Alger Management
New York
|
+$150M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$114M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$84.8M |
Top Sellers
| 1 |
Temasek Holdings
Singapore
|
-$200M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$123M |
| 3 |
Jennison Associates
New York
|
-$76.9M |
| 4 |
ClearBridge Investments
New York
|
-$49.8M |
| 5 |
State Street
Boston,
Massachusetts
|
-$48.5M |
